TCL Archive CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage. October 19, 2007
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center) October 28, 1988